Optimization of wet granulation process for manufacturing Rivaroxban generic immediate-release tablets using PBPK modeling and simulations-Reference-Cited by-同舟云学术

Optimization of wet granulation process for manufacturing Rivaroxban generic immediate-release tablets using PBPK modeling and simulations

Published:2024-08-22 Issue:2 Volume:12 Page:
ISSN:2193-9616
Container-title:In Silico Pharmacology
language:en
Short-container-title:In Silico Pharmacol.

Author:

Shiekmydeen Jailani^ORCID,Tanisha ^ORCID,Sharma Sonam^ORCID,Chakraborty Kishor,Kannaiyan Dhanapal Chidambaram^ORCID,Khan Noohu Abdulla^ORCID,Malayandi Rajkumar^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40203-024-00249-6.pdf

Reference25 articles.

1. Administrable O (2018) (12) United States Patent (45) Date of Patent: 2(12)

2. Alshihabi F, Vandamme T, Betz G (2013) Focused beam reflectance method as an innovative (PAT) tool to monitor in-line granulation process in fluidized bed. Pharm Dev Technol 18(1):73–84. https://doi.org/10.3109/10837450.2011.627868

3. Cheong EJY, Ng DZW, Chin SY, Wang Z, Chan ECY (2022) Application of a physiologically based pharmacokinetic model of rivaroxaban to prospective simulations of drug–drug–disease interactions with protein kinase inhibitors in cancer-associated venous thromboembolism. Br J Clin Pharmacol 88(5):2267–2283. https://doi.org/10.1111/bcp.15158

4. FDA & CDER (2011) Highlights of prescribing information. http://www.fda.gov/medwatch

5. Giry K, Viana M, Genty M, Louvet F, Wthrich P, Chulia D (2009) Comparison of single pot and multiphase granulation. Part 2: effect of the drying process on granules manufactured in a single pot granulator and dried either in situ or in a fluid bed dryer. Pharm Dev Technol 14(2):149–158. https://doi.org/10.1080/10837450802588942